Effects of maternal hyperphenylalaninemia on fetal brain development: a morphological study

Area of Science:

• Neuroscience
• Developmental Biology
• Toxicology

Background:

• Maternal hyperphenylalaninemia is a condition where elevated phenylalanine levels during pregnancy can negatively impact fetal development.
• Phenylalanine hydroxylase (PAH) deficiency or inhibition leads to hyperphenylalaninemia.
• Understanding the teratogenic effects of maternal hyperphenylalaninemia on brain development is crucial.

Purpose of the Study:

• To investigate the morphological effects of induced maternal hyperphenylalaninemia on fetal and neonatal rat brain development.
• To assess the extent of developmental delay and potential for recovery in the cerebral cortex.

Main Methods:

• Pregnant rats were administered alpha-methylphenylalanine (mPhe) and phenylalanine (Phe) to induce hyperphenylalaninemia.
• Embryonic and postnatal rat brains were examined morphologically at specific developmental stages.
• Cell death (pyknotic cells) and microglial response were quantified.

Main Results:

• Induced maternal hyperphenylalaninemia resulted in reduced cortical plate thickness and smaller neurons in fetal brains.
• Increased cell death and reactive microglia were observed in the fetal brains of treated rats.
• Postnatal development showed a reduction in morphological differences, with brains resembling controls by postnatal day 7.

Conclusions:

• Induced hyperphenylalaninemia causes significant delays in fetal cerebral cortex development.
• The developing rat brain exhibits a capacity for morphological recovery during the postnatal period.
• These findings highlight the critical impact of the prenatal environment on brain development and its potential for resilience.